FGD© (Future Generics Database)© presents:


the 2nd Generation anti-HCV Report

What: 30 APIs just launched or in advanced clinical trials.

When: Launched or due to be launched between years 2014 to 2018.

Where: US, EU and Japan.

Why buy: Best-in-class value, up-to-date, comprehensive and affordable.

Who: Business decision makers.



Report highlights:

Patents:

Production Process

New Application

Combinations

And Scientific References

Markets:

Status

Potential

Prices:

Price per box

Price per Kg

Price per treatment

when available

Dosages:

Stand alone

Combinations

Production Process:

Key Intermediates – Commercialized

Key Intermediates – Non-Commercialized

Reagents

Validated Suppliers




Contact us





Becker & Associates
6 rue de Parc Royal
75003 Paris, France
+33(0)1 48 87 75 44
sales@beckerdata.com